Behind the science
Meningitis cases continue to rebound post-pandemic
Scientific advances have helped reduce meningitis rates globally – but the need for awareness and innovation regarding prevention strategies continues. Here, one teenage patient tells her story – and what she wants others like her to know about the disease.
Our purpose
We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.Our R&D focus is on four therapeutic areas: infectious diseases, HIV, immunology/respiratory and oncology
Behind the science